Clinical Evaluation of Orphan Medical Devices: New Guidelines The new guidelines introduced by the European Commission address the clinical evaluation of orphan medical devices under the MDR, recognizing their un...
Guiding Principles for Transparent Machine Learning in Medical Devices The FDA, Health Canada, and the UK's MHRA have established guiding principles to enhance transparency in machine learning-enabled medical devices (MLM... Katarzyna Wesołowska Board Member
Webinar Announcement: Financing Conformity Assessment for Medical Devices On June 13th (Thursday) at 12:00 PM, we invite you to a free industry webinar with consultations, organized together with Frontline Biosciences S.A... Katarzyna Wesołowska Board Member
Participation in the International Clinical Trials Day Conference Yesterday, our colleagues Katarzyna Szatraj, PhD and Ilona Korczak-Cegielska attended a very interesting conference on the occasion of International C...
Our Representatives at the International Clinical Trials Day Conference Yesterday, our colleagues Katarzyna Szatraj, PhD and Ilona Korczak-Cegielska attended a very interesting conference on the occasion of International C... Katarzyna Wesołowska Board Member
CEOs of MDR Regulator and Pure Clinical Attend Kapitał Na Zdrowie Conference Today, Katarzyna Wesołowska and Adam Sobantka, the CEOs of MDR Regulator and Pure Clinical, are participating in the very interesting Kapitał Na Zdrow... Katarzyna Wesołowska Board Member
Get to know our new laboratory! This is another important news from the life of our group! Before the May weekend, our laboratory in Słupsk moved to an absolutely new, very spacious...
Our team during Conference on Polymers The 5th National Scientific Conference on Polymers in Medicine is Behind Us!... Katarzyna Wesołowska Board Member
26 May 2024 was the last call to apply for MDR for legacy devices and take advantage of the transitional periods 26 May 2024 was the last call to submit an application for MDR for legacy devices and take advantage of the transitional periods! The first condition...
